<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article  article-type="reviewer-report"        dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>j health sci med / jhsm</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Journal of Health Sciences and Medicine</journal-title>
            </journal-title-group>
                                        <issn pub-type="epub">2636-8579</issn>
                                                                                            <publisher>
                    <publisher-name>MediHealth Academy Yayıncılık</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id pub-id-type="doi">10.32322/jhsm.1626323</article-id>
                                                                <article-categories>
                                            <subj-group  xml:lang="en">
                                                            <subject>Dermatology</subject>
                                                            <subject>Cancer Therapy (Excl. Chemotherapy and Radiation Therapy)</subject>
                                                            <subject>Preventative Health Care</subject>
                                                            <subject>Podiatry</subject>
                                                    </subj-group>
                                            <subj-group  xml:lang="tr">
                                                            <subject>Dermatoloji</subject>
                                                            <subject>Kanser Tedavisi (Kemoterapi ve Radyoterapi hariç)</subject>
                                                            <subject>Koruyucu Sağlık Hizmetleri</subject>
                                                            <subject>Podiatri</subject>
                                                    </subj-group>
                                    </article-categories>
                                                                                                                                                        <title-group>
                                                                                                                        <trans-title-group xml:lang="tr">
                                    <trans-title>Kanser ve ayak sağlığı: onkoloji hastalarına özgü podolojik yaklaşımlar</trans-title>
                                </trans-title-group>
                                                                                                                                                                                                <article-title>Cancer and foot health: special podologic approaches to oncology patients</article-title>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-8479-0235</contrib-id>
                                                                <name>
                                    <surname>Sarpkaya</surname>
                                    <given-names>Ayşegül</given-names>
                                </name>
                                                                    <aff>HARRAN ÜNİVERSİTESİ</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-0343-5291</contrib-id>
                                                                <name>
                                    <surname>Küçük</surname>
                                    <given-names>Fatmaz Zehra</given-names>
                                </name>
                                                                    <aff>HARRAN UNIVERSITY</aff>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20250530">
                    <day>05</day>
                    <month>30</month>
                    <year>2025</year>
                </pub-date>
                                        <volume>8</volume>
                                        <issue>3</issue>
                                        <fpage>529</fpage>
                                        <lpage>534</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20250124">
                        <day>01</day>
                        <month>24</month>
                        <year>2025</year>
                    </date>
                                                    <date date-type="accepted" iso-8601-date="20250520">
                        <day>05</day>
                        <month>20</month>
                        <year>2025</year>
                    </date>
                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 2018, Journal of Health Sciences and Medicine</copyright-statement>
                    <copyright-year>2018</copyright-year>
                    <copyright-holder>Journal of Health Sciences and Medicine</copyright-holder>
                </permissions>
            
                                                                                                <trans-abstract xml:lang="tr">
                            <p>Kanser, dünya genelinde yüksek mortalite ve morbidite oranlarına sahip karmaşık bir hastalık grubudur. Bu hastalık grubunda kullanılan tedavi yöntemleri, yaşam kalitesini önemli ölçüde etkileyen cilt ve tırnak toksisiteleri, el-ayak sendromu ve periferik nöropati gibi yan etkilere yol açabilmektedir. Podoloji bilimi, bu etkilerin önlenmesi ve yönetilmesi açısından kritik bir rol oynamaktadır. Bu derleme, kanser tedavilerinde sıkça görülen ayak sağlığı sorunlarını, bu sorunların patofizyolojisini ve multidisipliner yaklaşımla sunulabilecek podolojik çözümleri sistematik bir şekilde ele almayı amaçlamaktadır. Ayrıca, Podologlar ve onkoloji uzmanlarının iş birliği ile ayak sağlığının korunmasının tedavi sürecindeki katkıları vurgulanmıştır. Derlemede, kemoterapi, radyoterapi ve immünoterapinin ayak sağlığı üzerindeki etkileri detaylandırılmış ve bu etkilerin yönetimi için uygulamalı öneriler sunulmuştur.</p></trans-abstract>
                                                                                                                                    <abstract><p>Cancer comprises a heterogeneous group of diseases associated with substantial global mortality and morbidity. Therapeutic modalities for these diseases frequently produce adverse effects-most notably skin and nail toxicities, hand-foot syndrome (HFS; palmar-plantar erythrodysesthesia), and peripheral neuropathy-that can markedly diminish patients’ quality of life. Podiatric care is therefore critical for preventing and mitigating these sequelae. In this review, we systematically examine the foot-related complications of cancer therapy, describe their underlying pathophysiology, and delineate multidisciplinary podiatric interventions. We also highlight the benefits of close collaboration between podiatrists and oncology specialists in maintaining foot health during treatment. Finally, we summarise the specific effects of chemotherapy, radiotherapy, and immunotherapy on the feet and provide evidence-based recommendations for their management.</p></abstract>
                                                            
            
                                                                                        <kwd-group>
                                                    <kwd>Cancer</kwd>
                                                    <kwd>  foot deformities</kwd>
                                                    <kwd>  nail toxicities</kwd>
                                                    <kwd>  podological care</kwd>
                                            </kwd-group>
                            
                                                <kwd-group xml:lang="tr">
                                                    <kwd>Ayak deformiteleri</kwd>
                                                    <kwd>  kanser</kwd>
                                                    <kwd>  podolojik bakım</kwd>
                                                    <kwd>  tırnak toksisiteleri</kwd>
                                            </kwd-group>
                                                                                                                                    <funding-group specific-use="FundRef">
                    <award-group>
                                                    <funding-source>
                                <named-content content-type="funder_name">None.</named-content>
                            </funding-source>
                                                                            <award-id>None</award-id>
                                            </award-group>
                </funding-group>
                                </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. doi:10. 3322/caac.21834</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">Kayıkçı EE, Can G. The effect of salt-water bath in the management of treatment-related peripheral neuropathy in cancer patients receiving taxane and platinum-based treatment. Explore (NY). 2022;18(3):347-356. doi:10.1016/j.explore.2021.07.002</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">Wan M, Luo X, Wang J, et al. The impact on quality of life from informing diagnosis in patients with cancer: a systematic review and meta-analysis. BMC Cancer. 2020;20(1):618. doi:10.1186/s12885-020-07096-6</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">Tachi T, Teramachi H, Tanaka K, et al. The impact of outpatient chemotherapy-related adverse events on the quality of life of breast cancer patients. PLoS One. 2015;10(4):e0124169. doi:10.1371/journal.pone.0124169</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">Hagiwara Y, Shiroiwa T, Shimozuma K, et al. Impact of adverse events on health utility and health-related quality of life in patients receiving first-line chemotherapy for metastatic breast cancer: results from the SELECT BC study. Pharmacoeconomics. 2018;36:215-223. doi:10.1007/s40273-017-0580-7</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">Lacouture ME, Kopsky DJ, Lilker R, et al. Podiatric adverse events and foot care in cancer patients and survivors: awareness, education, and literature review. J Am Podiatr Med Assoc. 2018;108(6):508-516. doi:10. 7547/17-010</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">Palomo-López P, Rodríguez-Sanz D, Becerro-de-Bengoa-Vallejo R, et al. Clinical aspects of foot health and their influence on quality of life among breast cancer survivors: a case-control study. Cancer Manag Res. 2017;9:545-551. doi:10.2147/CMAR.S151343</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">Nádašiová M. Podiatry, podology and pedicure. Int J Health New Technol Soc Work. 2018;13(4):4-10.</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">Gilbar P, Hain A, Peereboom VM. Nail toxicity induced by cancer chemotherapy. J Oncol Pharm Pract. 2009;15(3):143-155. doi:10.1177/ 1078155208100450</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">Saadet ED, Tek I. Evaluation of chemotherapy-induced cutaneous side effects in cancer patients. Int J Dermatol. 2022;61(12):1519-1526. doi:10. 1111/ijd.16361</mixed-citation>
                    </ref>
                                    <ref id="ref11">
                        <label>11</label>
                        <mixed-citation publication-type="journal">Pinto C, Barone CA, Girolomoni G, et al. Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy. Oncologist. 2011;16(2):228-238. doi:10. 1634/theoncologist.2010-0298</mixed-citation>
                    </ref>
                                    <ref id="ref12">
                        <label>12</label>
                        <mixed-citation publication-type="journal">Fabbrocini G, Cameli N, Romano MC, et al. Chemotherapy and skin reactions. J Exp Clin Cancer Res. 2012;31(1):50. doi:10.1186/1756-9966-31-50</mixed-citation>
                    </ref>
                                    <ref id="ref13">
                        <label>13</label>
                        <mixed-citation publication-type="journal">Li T, Perez-Soler R. Skin toxicities associated with epidermal growth factor receptor inhibitors. Target Oncol. 2009;4(2):107-119. doi:10.1007/s11523-009-0114-0</mixed-citation>
                    </ref>
                                    <ref id="ref14">
                        <label>14</label>
                        <mixed-citation publication-type="journal">Piraccini BM, Iorizzo M, Antonucci A, Tosti A. Drug-induced nail abnormalities. Expert Opin Drug Saf. 2004;3(1):57-65. doi:10.1517/1474 0338.3.1.57</mixed-citation>
                    </ref>
                                    <ref id="ref15">
                        <label>15</label>
                        <mixed-citation publication-type="journal">Singal A, Bisherwal K. Melanonychia: etiology, diagnosis, and treatment. Indian Dermatol Online J. 2020;11(1):1-11. doi:10.4103/idoj.IDOJ_167_19</mixed-citation>
                    </ref>
                                    <ref id="ref16">
                        <label>16</label>
                        <mixed-citation publication-type="journal">Samson P, Curvale C, Iniesta A, Gay A. Managing longitudinal melanonychia. Hand Surg Rehabil. 2024;43S:101526. doi:10.1016/j.hansur.2022.12.007</mixed-citation>
                    </ref>
                                    <ref id="ref17">
                        <label>17</label>
                        <mixed-citation publication-type="journal">Robert C, Sibaud V, Mateus C, et al. Nail toxicities induced by systemic anticancer treatments. Lancet Oncol. 2015;16(4):e181-e189. doi:10.1016/S1470-2045(14)71133-7</mixed-citation>
                    </ref>
                                    <ref id="ref18">
                        <label>18</label>
                        <mixed-citation publication-type="journal">Alizadeh N, Mirpour SH, Darjani A, Rafiei R, Rafiei E, Mohammadhoseini M. Dermatologic adverse effects of breast cancer chemotherapy: a longitudinal prospective observational study with a review of literature. Int J Dermatol. 2020;59(7):822-828. doi:10.1111/ijd. 14916</mixed-citation>
                    </ref>
                                    <ref id="ref19">
                        <label>19</label>
                        <mixed-citation publication-type="journal">Cuervo-Maldonado SI, Álvarez-Rodríguez JC, Cubides CL, et al. Fusariosis in cancer patients: 13 case series report and literature review. Biomedica. 2023;43(Sp. 1):41-56. doi:10.7705/biomedica.6925</mixed-citation>
                    </ref>
                                    <ref id="ref20">
                        <label>20</label>
                        <mixed-citation publication-type="journal">Kwakman JJM, Elshot YS, Punt CJA, Koopman M. Management of cytotoxic chemotherapy-induced hand-foot syndrome. Oncol Rev. 2020; 14(1):442. doi:10.4081/oncol.2020.442</mixed-citation>
                    </ref>
                                    <ref id="ref21">
                        <label>21</label>
                        <mixed-citation publication-type="journal">Miller KK, Gorcey L, McLellan BN. Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management. J Am Acad Dermatol. 2014;71(4):787-794. doi:10.1016/j.jaad.2014.03.019</mixed-citation>
                    </ref>
                                    <ref id="ref22">
                        <label>22</label>
                        <mixed-citation publication-type="journal">Li Y, Huang W, Zhang L, et al. Evaluation of the preventive effect of regional cooling nursing on hand-foot syndrome caused by doxorubicin hydrochloride liposome. Open J Nurs. 2022;12(11):772-781. doi:10.4236/ojn.2022.1211054</mixed-citation>
                    </ref>
                                    <ref id="ref23">
                        <label>23</label>
                        <mixed-citation publication-type="journal">Bun S, Yunokawa M, Tamaki Y, et al. Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer. Support Care Cancer. 2018;26: 2161-2166. doi:10.1007/s00520-018-4054-z</mixed-citation>
                    </ref>
                                    <ref id="ref24">
                        <label>24</label>
                        <mixed-citation publication-type="journal">Tofthagen C, Overcash J, Kip K. Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Cancer. 2012;20(3):583-589. doi:10.1007/s00520-011-1127-7</mixed-citation>
                    </ref>
                                    <ref id="ref25">
                        <label>25</label>
                        <mixed-citation publication-type="journal">Cathcart-Rake EJ, Hilliker DR, Loprinzi CL. Chemotherapy-induced neuropathy: central resolution of a peripherally perceived problem? Cancer. 2017;123(11):1898-1900. doi:10.1002/cncr.30650</mixed-citation>
                    </ref>
                                    <ref id="ref26">
                        <label>26</label>
                        <mixed-citation publication-type="journal">Veiga-Seijo R, González-Bartol E, Pérez-Ríos N, Pazos-Couselo M, Romero-Bernárdez D, Seoane-Pillado T. Wellbeing and complementary therapies in breast cancer peripheral neuropathy care: a scoping review focused on foot health. Cancers (Basel). 2023;15(7):2110. doi:10.3390/cancers15072110</mixed-citation>
                    </ref>
                                    <ref id="ref27">
                        <label>27</label>
                        <mixed-citation publication-type="journal">Čeović R, Kovačec L, Bukvić Mokos Z, Marinović B. Dermatologic adverse events in oncologic therapies. Acta Dermatovenerol Croat. 2022; 30(4):237-249.</mixed-citation>
                    </ref>
                                    <ref id="ref28">
                        <label>28</label>
                        <mixed-citation publication-type="journal">Alley E, Green R, Schuchter L. Cutaneous toxicities of cancer therapy. Curr Opin Oncol. 2002;14(2):212-216. doi:10.1097/00001622-200203000-00012</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
